Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abonia

Showing results (111-120 of 170) with videos related to

Pageof 17
Sort By:
The Journal of Allergy and Clinical Immunology|December 13, 2007
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoidsCarine Blanchard, Melissa K Mingler, Maria Vicario, et al.
European Journal of Medicinal Chemistry|March 1, 2015
An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agentsBraulio Insuasty, Juan Ramírez, Diana Becerra, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2017
Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease lociLisa J Martin, Hua He, Margaret H Collins, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 30, 2022
Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiencyH Richard Droghini, J Pablo Abonia, Margaret H Collins, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2011
Long-term outcomes in pediatric-onset esophageal eosinophiliaCharles W DeBrosse, James P Franciosi, Eileen C King, et al.
The Journal of Allergy and Clinical Immunology. Global|April 22, 2026
Peanut oral immunotherapy at a single academic medical center using a volume-based approach with store-purchased peanut productsAshley L Devonshire, Adam Z Magier, Bridget E Wilson, et al.
The Journal of Allergy and Clinical Immunology|July 13, 2010
Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999Charles W DeBrosse, Margaret H Collins, Bridget K Buckmeier Butz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2008
Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic casesMargaret H Collins, Carine Blanchard, J Pablo Abonia, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2011
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trialJonathan M Spergel, Marc E Rothenberg, Margaret H Collins, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 10, 2016
Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoringM H Collins, L J Martin, E S Alexander, et al.
Pageof 17

Showing results (111-120 of 170) with videos related to

Sort By:
Pageof 17
The Journal of Allergy and Clinical Immunology|December 13, 2007
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoidsCarine Blanchard, Melissa K Mingler, Maria Vicario, et al.
European Journal of Medicinal Chemistry|March 1, 2015
An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agentsBraulio Insuasty, Juan Ramírez, Diana Becerra, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2017
Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease lociLisa J Martin, Hua He, Margaret H Collins, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 30, 2022
Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiencyH Richard Droghini, J Pablo Abonia, Margaret H Collins, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2011
Long-term outcomes in pediatric-onset esophageal eosinophiliaCharles W DeBrosse, James P Franciosi, Eileen C King, et al.
The Journal of Allergy and Clinical Immunology. Global|April 22, 2026
Peanut oral immunotherapy at a single academic medical center using a volume-based approach with store-purchased peanut productsAshley L Devonshire, Adam Z Magier, Bridget E Wilson, et al.
The Journal of Allergy and Clinical Immunology|July 13, 2010
Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999Charles W DeBrosse, Margaret H Collins, Bridget K Buckmeier Butz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2008
Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic casesMargaret H Collins, Carine Blanchard, J Pablo Abonia, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2011
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trialJonathan M Spergel, Marc E Rothenberg, Margaret H Collins, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 10, 2016
Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoringM H Collins, L J Martin, E S Alexander, et al.
Pageof 17